Archived Insight | April 25, 2019

Incident Response Plans: Be Prepared for a Data Breach

As plan fiduciaries, sponsors are ultimately responsible for data protection. That’s true even when day-to-day cybersecurity is delegated to the third-party administrator (TPA) handling benefits administration.

That’s why it’s important for sponsors of plans with outsourced administration to oversee cybersecurity and create an incident response plan.

Have a question? We have answers.

Send us a message. 

Speak with Us

Key aspects of cybersecurity oversight

Thorough oversight of outsourced cybersecurity includes these steps:

It’s also important for plan sponsors with outsourced administration to have an incident-response plan they can follow in the event of an actual data breach.

What to include in an incident response plan when you've outsourced to a TPA

You'll need an incident response plan even if you've outsourced all of your administration tasks to a TPA. To develop a meaningful incident response plan in this scenario, address all of the following:

Be prepared — and avoid finger-pointing

Monitoring outsourced cybersecurity gives you confidence that your plan data is being adequately protected.

Creating an incident response plan helps ensure you’ll be prepared to respond if plan data is breached. If you’ve outsourced functions to more than one vendor, having an incident response plan will help avoid finger-pointing among vendors in the event of a breach.

Read other insights

Asian Female Pharmacist Uses Computer To Check Inventory For A Drug

Designing and Negotiating Affordable Pharmacy Benefits

Learn how health plan sponsors can improve pharmacy benefit value through PBM contracting, formulary management and clinical oversight.
Focused Business Woman Working On Laptop Computer Reading

Many Retirement Plans Must Be Amended by December 31, 2026

Learn which retirement plans must be amended by December 31, 2026 and how SECURE Act discretionary and required amendments differ.
Man Self Injecting GLP 1 Weight Loss Medication Pen At Home

GLP-1s Have Disrupted the Market for Other Diabetes Drugs

Segal’s SHAPE data shows how rising GLP-1 use coincided with declines in insulin, Metformin and DPP-4 inhibitor use.

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.